US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Pharmaceuticals ETF

101.07

-0.2000-0.20%

Post-market: 101.070.00000.00%19:30 EDT

Volume:99.78K

Turnover:10.11M

Market Cap:1.62B

PE:9.41

High:102.12

Open:101.96

Low:101.00

Close:101.27

52wk High:108.66

52wk Low:69.02

Shares:16.00M

Float Shares:16.00M

Volume Ratio:0.68

T/O Rate:0.62%

Dividend:1.47

Dividend Rate:1.45%

EPS(TTM):10.74

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Merck & Co Inc : Leerink Partners Raises Target Price to $161 from $127

THOMSON REUTERS

Merck price target raised to $161 from $127 at Leerink

CD&R Appoints Novartis Chair Giovanni Caforio Operating Advisor to Funds

Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty Pharma (RPRX)

Atai Beckley Holds Shareholder Meeting, Quorum Met with 65.6% Shares Represented

Medtronic PLC Stock Outperforms Competitors Despite Losses on the Day

Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared to Competitors

Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day

Protagonist Therapeutics Launches USD 300 Million Share Buyback Program

Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.25% on Sep 8: Facts Behind the Movement

Eli Lilly Stock (LLY) Falls on Competitor Novartis’ Cholesterol Drug Setback

Royalty Pharma Down Nearly 6%, on Pace for Largest Percent Decrease Since March 2025

Royalty Pharma Falls After Novartis' Cholesterol Drug Fails in Study

Dow Drops 438 Points on Losses for Amgen, Salesforce Shares

Johnson & Johnson Innovation Names Silvia Chen Head of JLABS Shanghai

Bristol Myers Squibb's Phase 2 Study of Arlocabtagene Autoleucel Meets Key Endpoints

MT Newswires Live

Bristol Myers’ arlocabtagene autoleucel shows positive results in Phase 2 trial

Bristol Myers Squibb's Therapy Meets Mid-Stage Trial Goal

Bristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 Quintessential Trial of the Potential First-in-Class Gprc5d-Directed Car T Cell Therapy, Arlocabtagene Autoleucel ...

THOMSON REUTERS

Bristol-Myers Squibb Company - Phase 2 Trial Met Primary Endpoint of Overall Response Rate and Complete Response Rate

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/IHE/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IHE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IHE\",,,,,undefined,":{"symbol":"IHE","market":"US","secType":"STK","nameCN":"iShares U.S. Pharmaceuticals ETF","latestPrice":101.07,"timestamp":1789156800000,"preClose":101.27,"halted":0,"volume":99783,"hourTrading":{"tag":"盘后","latestPrice":101.07,"preClose":101.07,"latestTime":"19:30 EDT","volume":196,"amount":19824.83,"timestamp":1789169406262,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0019749185346104757,"floatShares":16000000,"shares":16000000,"eps":10.735807,"marketStatus":"Market Closed","change":-0.2,"latestTime":"09-11 16:00:00 EDT","open":101.96,"high":102.12,"low":101,"amount":10113839.24022,"amplitude":0.01106,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":10.735807,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":101.27,"sharesOutstanding":11650000,"nav":101.260182,"aum":1620162912,"dividendRate":0.014529,"bidAskSpread":0.000818,"preHourTrading":{"tag":"盘前","latestPrice":101.28,"preClose":101.27,"latestTime":"09:28 EDT","volume":8,"amount":811.75512,"timestamp":1789133285218,"change":0.01,"changeRate":0.000099,"amplitude":0.013034},"postHourTrading":{"tag":"盘后","latestPrice":101.07,"preClose":101.07,"latestTime":"19:30 EDT","volume":196,"amount":19824.83,"timestamp":1789169406262,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6832009368581358,"impliedVol":0.1843,"impliedVolPercentile":0.9761},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IHE\",,,,,undefined,":{"symbol":"IHE","floatShares":16000000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6832009368581358,"shares":16000000,"dividePrice":1.4684,"high":102.12,"amplitude":0.01106,"preClose":101.27,"low":101,"week52Low":69.02,"pbRate":"--","week52High":108.66,"institutionHeld":0,"latestPrice":101.07,"eps":10.735807,"divideRate":0.014529,"volume":99783,"delay":0,"ttmEps":10.735807,"open":101.96,"prevYearClose":84.83,"prevWeekClose":104.68,"prevMonthClose":103.64,"prevQuarterClose":99.01,"fiveDayClose":105.42,"twentyDayClose":102.99,"sixtyDayClose":93.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IHE\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IHE","amount":0.284781,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares U.S. Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IHE","amount":0.284491,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"iShares U.S. Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IHE","amount":0.585254,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares U.S. Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IHE","amount":0.312397,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"iShares U.S. Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-06-16","symbol":"IHE","amount":0.306536,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares U.S. Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IHE\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.315888,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-28","value":0.33773,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.358233,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.91844,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.449501,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IHE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IHE\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666258492","title":"Merck & Co Inc : Leerink Partners Raises Target Price to $161 from $127","url":"https://stock-news.laohu8.com/highlight/detail?id=2666258492","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666258492?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:17","pubTimestamp":1788949066,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nFWN4510IW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GDOC","IXJ","LU1989772840.SGD","LU2023250504.SGD","LU1093756325.SGD","LU1037948897.HKD","BK4585","LU1032466523.USD","IE00BBT3K403.USD","LU0234572021.USD","LU0320765489.SGD","LU1923622614.USD","LU0124676726.USD","LU1066051225.USD","SG9999015358.SGD","LU1983299246.USD","VHT","LU1934455863.HKD","SG9999015341.SGD","BK4559","SG9999014559.SGD","IHE","LU0265550946.USD","LU2357627491.SGD","LU1989772923.USD","LU0477156953.USD","MRK","LU0006306889.USD","LU2106854487.HKD","SG9999002224.SGD","LU1934455194.USD","LU1571399168.USD","LU1917777945.USD","LU1066051498.USD","BK4550","LU2125909593.SGD","LU2023250843.SGD","LU1057294990.SGD","LU0965509101.SGD","LU2324357040.USD","IE00BJT1NW94.SGD","LU0130517989.USD","IE0009355771.USD","LU1035773651.USD","SG9999014575.USD","SGXZ57979304.SGD","SG9999001176.SGD","LU0965509010.AUD","LU0130102774.USD","LU1037948541.HKD","LU0211331839.USD","LU1066053197.SGD","TRUH","LU0070302665.USD","IE00BFTCPJ56.SGD","PPH","SG9999001176.USD","FTXH","SG9999014542.SGD","JDOC","IE00BLSP4239.USD","LU2491049909.HKD","LU1066051811.HKD","LU1201861249.SGD","LU0985320562.USD","LU2125909247.SGD","LU0980610538.SGD","LU0861579265.USD","LU2433249047.HKD","LU2089984988.USD","SG9999013999.USD","LU1934455277.USD","LU1061106388.HKD","BK4588","LU0238689110.USD","LU0098860793.USD","LU1585245621.USD","LU0265550359.USD","LU0289739699.SGD","LU1162221912.USD","LU0965508806.USD","BK4516","BK4533","BK4534","LU1941712348.USD","SG9999002232.USD","LU1929549753.HKD","LU1116320901.HKD","LU1116320737.USD","LU0058720904.USD","LU2491050071.SGD","XLV","LU1023059063.AUD","LU0266013472.USD","LU2491050154.USD","LU1291159041.SGD","LU2468319806.SGD","LU0823416689.USD","IE00BLSP4452.SGD","FHLC","LU1974910355.USD","IE0002141913.USD","LU2125154935.USD","LU2461242641.AUD","LU0106261372.USD","LU2360032135.SGD","LU2125154778.USD","LU1699723380.USD","IE00BSNM7G36.USD","RXL","LU0122379950.USD","LU1069347547.HKD","HRTS","LU0689626769.HKD","LU1093756168.USD","IE00B2B36J28.USD","IE00BN8TJ469.HKD","LU1989771016.USD","LU0965509283.SGD","LU0868494708.USD","LU2361044865.SGD","LU0942090050.USD","LU0320765646.SGD","IE000M9KFDE8.USD","LU1430594728.SGD","PAWZ","SG9999014567.USD","LU0859254822.USD","IE00B4R5TH58.HKD","LU0203347892.USD","LU0432979614.USD","LU1941712264.USD","IE00BJJMRZ35.SGD","LU2361045086.USD","LU2361044949.HKD","LU0208291251.USD","LU0648001328.SGD","LU0868494617.USD","LU2112291526.USD","IE00B1BXHZ80.USD","IYH","LU0203345920.USD","BMED","BK4007","SG9999001440.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666450584","title":"Merck price target raised to $161 from $127 at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2666450584","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666450584?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:10","pubTimestamp":1788948612,"startTime":"0","endTime":"0","summary":"Leerink raised the firm’s price target on Merck (MRK) to $161 from $127 and keeps an Outperform rating on the shares. Published first on TheFly – t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/merck-price-target-raised-to-161-from-127-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/merck-price-target-raised-to-161-from-127-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0648001328.SGD","LU0130102774.USD","LU1035773651.USD","BK4559","IE000M9KFDE8.USD","LU0211331839.USD","LU2491050071.SGD","LU1974910355.USD","BMED","SG9999014559.SGD","LU2491050154.USD","LU2491049909.HKD","FTXH","IE00BN8TJ469.HKD","BK4534","LU1093756168.USD","LU2125909247.SGD","LU0965508806.USD","LU1162221912.USD","LU1057294990.SGD","SG9999014575.USD","IE00B2B36J28.USD","LU1989772923.USD","LU1037948541.HKD","IE00BBT3K403.USD","LU0058720904.USD","LU2125909593.SGD","LU1201861249.SGD","LU2089984988.USD","LU0006306889.USD","IE0002141913.USD","LU0106261372.USD","LU2023250504.SGD","LU0477156953.USD","IE00BLSP4452.SGD","BK4516","LU2106854487.HKD","IHE","LU1917777945.USD","XLV","LU0965509010.AUD","LU1983299246.USD","LU2461242641.AUD","HRTS","LU2360032135.SGD","LU0689626769.HKD","JDOC","LU2361044865.SGD","LU1032466523.USD","LU1066051225.USD","LU1929549753.HKD","LU0265550946.USD","LU2125154935.USD","LU0266013472.USD","BK4588","IE00B1BXHZ80.USD","LU2023250843.SGD","LU1069347547.HKD","LU1116320737.USD","TRUH","SG9999001176.USD","LU1923622614.USD","LU1941712264.USD","SG9999002232.USD","IE0009355771.USD","LU0985320562.USD","PAWZ","IE00BJJMRZ35.SGD","LU2361044949.HKD","IE00B4R5TH58.HKD","LU2433249047.HKD","LU0965509283.SGD","LU0965509101.SGD","LU1116320901.HKD","RXL","LU1989772840.SGD","LU1934455194.USD","SG9999015358.SGD","IE00BLSP4239.USD","LU0203345920.USD","IE00BSNM7G36.USD","BK4550","LU1989771016.USD","LU1291159041.SGD","IE00BJT1NW94.SGD","LU1699723380.USD","LU0861579265.USD","LU0432979614.USD","LU1066053197.SGD","BK4585","VHT","LU1934455277.USD","SG9999015341.SGD","LU1934455863.HKD","SG9999002224.SGD","LU1093756325.SGD","LU0868494708.USD","LU0942090050.USD","LU2357627491.SGD","FHLC","LU1061106388.HKD","LU0130517989.USD","SGXZ57979304.SGD","SG9999001440.SGD","LU0823416689.USD","SG9999001176.SGD","IXJ","LU0098860793.USD","LU0238689110.USD","LU2112291526.USD","LU1023059063.AUD","LU1585245621.USD","SG9999013999.USD","LU2361045086.USD","LU0208291251.USD","BK4007","LU0122379950.USD","SG9999014567.USD","LU1430594728.SGD","BK4533","LU0859254822.USD","LU0203347892.USD","LU2468319806.SGD","PPH","LU0234572021.USD","LU0320765489.SGD","IYH","IE00BFTCPJ56.SGD","MRK","LU1066051498.USD","LU0070302665.USD","LU0868494617.USD","LU0980610538.SGD","LU2324357040.USD","GDOC","LU1066051811.HKD","LU0265550359.USD","LU0289739699.SGD","SG9999014542.SGD","LU0124676726.USD","LU1571399168.USD","LU1941712348.USD","LU0320765646.SGD","LU2125154778.USD","LU1037948897.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666837885","title":"CD&R Appoints Novartis Chair Giovanni Caforio Operating Advisor to Funds","url":"https://stock-news.laohu8.com/highlight/detail?id=2666837885","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666837885?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:01","pubTimestamp":1788940865,"startTime":"0","endTime":"0","summary":"CD&R appoints Novartis Chair Giovanni Caforio operating advisor to fundsClayton, Dubilier & Rice named Giovanni Caforio an operating advisor to its funds, focusing on healthcare investment sourcing an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL9wnhr1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","BK4581","FTXH","LU1883839398.USD","LU2133065610.SGD","LU1291159041.SGD","LU1989771016.USD","LU0306807586.USD","LU1670711040.USD","LU1571399168.USD","LU0985481810.HKD","LU0321505868.SGD","BK4532","LU1868836757.USD","LU1074936037.SGD","LU0225771236.USD","IE00BSNM7G36.USD","LU0432979614.USD","LU0306806265.USD","LU0882574055.USD","LU1236620750.USD","LU1032466523.USD","IE0009355771.USD","LU0237698245.USD","LU1868836591.USD","IE00BJJMRZ35.SGD","LU1718418525.SGD","LU0096364046.USD","LU2242646821.SGD","IE00B2B36J28.USD","LU0321505439.SGD","LU2596442595.SGD","BK4534","LU2242652126.USD","IE00BFTCPJ56.SGD","LU1261432733.SGD","IE00BJT1NW94.SGD","LU1585245621.USD","BK4588","LU0114720955.EUR","LU2360032135.SGD","LU1093756168.USD","LU1236620834.HKD","IE00BFXG1179.USD","BMY","IHE","LU1323610961.USD","LU0061475181.USD","LU1670710661.SGD","LU1868837136.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666630973","title":"Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty Pharma (RPRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666630973","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666630973?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:30","pubTimestamp":1788921013,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN), Beam Therapeutics (BEAM) and Royalty...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-amgen-amgn-beam-therapeutics-beam-and-royalty-pharma-rprx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-amgen-amgn-beam-therapeutics-beam-and-royalty-pharma-rprx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","IE0002141913.USD","LU0889565916.HKD","TBXU","BK4535","LU1061106388.HKD","PBE","IE00B4R5TH58.HKD","BK4007","IHE","IBB","IE00B2B36J28.USD","LU1023059063.AUD","BEAM","AMGN","LU2242646821.SGD","LABU","SG9999001440.SGD","LU1861559042.SGD","PJP","LU1057294990.SGD","BK4566","BK4611","BK4534","LU1861558580.USD","LU0029874061.USD","LU2242652126.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU2468319806.SGD","BK4139","IE00BJJMRZ35.SGD","RPRX","BK4599","LU0868494617.USD","BK4505","LU1983299246.USD","LU2112291526.USD","BBH","BK4533","BK4137","IE0009355771.USD","BK4588","BIB","XBI","IBBQ","XLV","HCSG","LU0289739699.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370615","title":"Atai Beckley Holds Shareholder Meeting, Quorum Met with 65.6% Shares Represented","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370615","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370615?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:10","pubTimestamp":1788901814,"startTime":"0","endTime":"0","summary":"Atai Beckley holds shareholder meeting, quorum met with 65.6% shares representedAtai Beckley held a virtual special shareholder meeting on Sept. 8, 2026 to vote on a merger agreement with Eli Lilly.Sh","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL1JLSHz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2213496289.HKD","FHLC","LU1548497426.USD","LU2237443622.USD","BK4516","LU0210536198.USD","LU1623119135.USD","LU0096364046.USD","SGXZ31699556.SGD","XLV","LU0158827781.USD","LU0820561818.USD","ILDR","IE00B1BXHZ80.USD","LU0823434583.USD","IE00BK4W5L77.USD","BK4539","IE0005OL40V9.USD","LU0943347566.SGD","IXJ","BK4533","GDOC","LU2756315318.SGD","LU2357305700.SGD","LU0316494557.USD","SG9999001176.USD","IE00BJJMRZ35.SGD","LU1868836757.USD","JDOC","LU0106261372.USD","LU2237443895.HKD","LU0354030438.USD","LU2324357040.USD","LU2471134796.USD","LU2063271972.USD","IE00BFTCPJ56.SGD","TMED","LU2552382215.SGD","LU1551013342.USD","LU0385154629.USD","LU0345770308.USD","LU1127390331.HKD","LU0061475181.USD","LU1323610961.USD","LU0203202063.USD","LU2471134879.HKD","LU0114720955.EUR","LU0889565916.HKD","LU1093756168.USD","LU1712237335.SGD","LU2111349929.HKD","IE0004445015.USD","SG9999014906.USD","IE00BJJMRY28.SGD","LU2108987350.USD","LU2265009873.SGD","LU2491050071.SGD","SG9999013999.USD","SGXZ99366536.SGD","CANC","IE00BFSS8Q28.SGD","LU0689472784.USD","LU1720051017.SGD","LU2168564065.EUR","LU2237443382.USD","SG9999014898.SGD","LU2750360997.AUD","LU2023251221.USD","IE00BKPKM429.USD","LU0787776722.HKD","LU1064131342.USD","LU0203201768.USD","LU2087625088.SGD","SG9999017495.SGD","RXL","LU2089284900.SGD","LU0786609619.USD","BK4581","LU0174119429.USD","LU2417539215.USD","LU0289739699.SGD","BK4585","LU2361044865.SGD","LU0882574139.USD","IE00B4JS1V06.HKD","VHT","LU1814569148.SGD","PJP","LU2211815571.USD","LU0820561909.HKD","LU2023250504.SGD","LU2468319806.SGD","LU2491050154.USD","BK4588","LU0471298777.SGD","LU0432979614.USD","LU2746668461.USD","LU0256863811.USD","LU0122379950.USD","LU0266013472.USD","SG9999018857.SGD","LLII","LU0109391861.USD","LU0006306889.USD","LU1868836914.USD","LU2491049909.HKD","LU2471134952.CNY","LU0353189763.USD","LU1551013425.SGD","LU2271345857.HKD","LU1868837136.USD","SG9999015952.SGD","LU0354030511.USD","LU1868837300.USD","SGXZ51526630.SGD","LU0882574055.USD","ATAI","LU2461242641.AUD","LU2168563687.JPY","BK4534","LU2361045086.USD","LU0198837287.USD","LU2462591350.SGD","LU1061106388.HKD","LU1989771016.USD","SG9999014880.SGD","SG9999018865.SGD","IE00BK4W5M84.HKD","LU1023059063.AUD","LU1917777945.USD","LU2471134523.USD","IE00B775H168.HKD","LU1291159041.SGD","LU2264538146.SGD","LU0353189680.USD","LU0158827948.USD","LU1280957306.USD","LU2237443549.SGD","LU0094547139.USD","MHIP","LU0708995401.HKD","LLYZ","IE0004445239.USD","LU0323591593.USD","LU0672654240.SGD","LU1145028129.USD","THNR","LU0225283273.USD","FTXH","IE0002141913.USD","LU2750360641.GBP","LU1069344957.HKD","LU2756315664.SGD","LU1868836591.USD","CURE","BK4007","LU0320765992.SGD","LU0133085943.USD","LU0234572021.USD","LU0256863902.USD","LU0471298694.HKD","LU2112291526.USD","SG9999015986.USD","WDNA","LU0417517546.SGD","IHE","GB00BDT5M118.USD","LU2106854487.HKD","ELIS","IYH","LU0097036916.USD","SG9999001176.SGD","LU0820562030.AUD","LU0640476718.USD","LU2462157665.USD","LU2360106947.USD","LU1267930730.SGD","LU0058720904.USD","LU2361044949.HKD","LU1983299246.USD","LU2089283258.USD","MEDI","HRTS","LU2028103732.USD","IE0009355771.USD","LU2896262040.SGD","LU2089984988.USD","LU2237443465.HKD","LU0823434740.USD","LU2168564495.EUR","SGXZ57979304.SGD","IE00BJJMRX11.SGD","IE00BWXC8680.SGD","LU1232071149.USD","IE00BFSS7M15.SGD","LU0964807845.USD","IE00B1XK9C88.USD","LU1979441026.SGD","LU0823416689.USD","IE00BJT1NW94.SGD","LU2552382132.HKD","LU0238689110.USD","SG9999014914.USD","AGNG","SG9999015945.SGD","TRUH","LU2602419157.SGD","LU0683600562.USD","LU0345770993.USD","LU2237438978.USD","IE00B4R5TH58.HKD","LU0320765059.SGD","LU2168564149.EUR","SGXZ81514606.USD","LU2023250330.USD","SG9999015978.USD","LLY","LU0079474960.USD","LU1804176565.USD","LU2237443978.SGD","ELIL","LU1366192091.USD","LU1035775433.USD","IE00B2B36J28.USD","BK4599","LU1691799644.USD","LU2168564222.USD","LU1093756325.SGD","OZEM","LU1974910355.USD","LU2236285917.USD","IE00B7KXQ091.USD","IE00BN29S564.USD","LU1629891620.HKD","LU0456855351.SGD","LU1720051108.HKD","LU2456880835.USD","IE00BJLML261.HKD","LU0109394709.USD","IE0001KFT4U8.USD","LU2552382058.USD","LU0466842654.USD","LU1057294990.SGD","PPH","IE00BKDWB100.SGD","MEDX","LU2746668974.SGD","LU1988902786.USD","LLYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666243377","title":"Medtronic PLC Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2666243377","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666243377?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:38","pubTimestamp":1788899880,"startTime":"0","endTime":"0","summary":"DJ Medtronic PLC Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Medtronic PLC  slid 1.89% to $92.39 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.58% to 7,673.52 and Dow Jones Industrial Average  falling 1.18% to 52,786.07.The stock's fall snapped a four-day winning streak.Medtronic PLC closed 13.11% below its 52-week high of $106.33, which the company reached on November 26th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 2.22% to $269.12, Danaher Corp.  fell 1.17% to $205.23, and Abbott Laboratories  fell 2.59% to $105.52.Trading volume  eclipsed its 50-day average volume of 7.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","JDOC","IE00B3T34201.USD","DHR","LU0122379950.USD","SG9999002232.USD","RXL","XLV","LU1721429741.USD","FHLC","IXJ","LU1670627923.USD","PJP","IE000WAW04H5.SGD","ABT","LU0234572021.USD","LU0320765059.SGD","LU1061106388.HKD","LU0158827781.USD","FMED","BK4581","TRUH","LU0496365809.HKD","FTXH","LU0289960550.SGD","LU0162691827.USD","LU2211814178.USD","MDT","LU2063271972.USD","LU2125910179.SGD","LU0170899867.USD","IHE","VHT","IYH","LU1989763690.USD","IE00BN8TJ469.HKD","SG9999013999.USD","JNJ","LU1894683348.USD","GDOC","LU1791710400.SGD","TMED","IHI","IE00BJT1NW94.SGD","LU2129689431.USD","LU1261432733.SGD","LU1280957306.USD","BK4534","BMED","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377291","title":"Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377291","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377291?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:37","pubTimestamp":1788899820,"startTime":"0","endTime":"0","summary":"DJ Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Bristol Myers Squibb Co.  slipped 3.19% to $64.69 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.58% to 7,673.52 and Dow Jones Industrial Average  falling 1.18% to 52,786.07.This was the stock's second consecutive day of losses.Bristol Myers Squibb Co. closed 5.75% short of its 52-week high of $68.64, which the company reached on August 19th.The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 2.22% to $269.12, Pfizer Inc.  fell 2.32% to $27.79, and Abbott Laboratories  fell 2.59% to $105.52.Trading volume  remained 1.3 million below its 50-day average volume of 10.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU1074936037.SGD","BK4532","LU0225284248.USD","LU0456855351.SGD","LU1670710588.SGD","LU0306807586.USD","BK4007","LU1571399168.USD","LU0061475181.USD","LU1868837300.USD","LU1291159041.SGD","LU2133065610.SGD","LU0306806265.USD","LU1236620750.USD","BMY","LU1032466523.USD","LU1989771016.USD","LU1323610961.USD","BK4588","LU2125154778.USD","LU0096364046.USD","LU1718418525.SGD","LU1093756325.SGD","LU1236620834.HKD","LU0868494617.USD","LU2242652126.USD","LU0321505439.SGD","LU0432979614.USD","BK4581","IE00BFTCPJ56.SGD","LU0114720955.EUR","FTXH","LU1983299246.USD","LU2360032135.SGD","LU1670710661.SGD","LU1868836914.USD","LU1868836591.USD","LU0985481810.HKD","LU1883839398.USD","IE0002141913.USD","LU0225771236.USD","BK4559","IHE","LU0321505868.SGD","LU1670711123.USD","IE00BJJMRZ35.SGD","LU0237698245.USD","LU2125154935.USD","IE00BSNM7G36.USD","LU1868837136.USD","LU1585245621.USD","LU2596442595.SGD","LU0267386448.USD","LU1430594728.SGD","LU2242646821.SGD","LU1093756168.USD","IE00B2B36J28.USD","IE0009355771.USD","IE00BFXG1179.USD","IE00BJT1NW94.SGD","LU1670711040.USD","LU1261432733.SGD","BK4534","BK4585","LU1868836757.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666104377","title":"Merck & Co. Inc. Stock Outperforms Competitors Despite Losses on the Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2666104377","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666104377?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:33","pubTimestamp":1788899580,"startTime":"0","endTime":"0","summary":"DJ Merck & Co. Inc. Stock Outperforms Competitors Despite Losses On The DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Merck & Co. Inc.  slipped 1.24% to $148.46 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.58% to 7,673.52 and Dow Jones Industrial Average  falling 1.18% to 52,786.07.This was the stock's second consecutive day of losses.Merck & Co. Inc. closed 5.39% short of its 52-week high of $156.92, which the company reached on August 25th.Despite its losses, the stock outperformed some of its competitors Tuesday, as Johnson & Johnson  fell 2.22% to $269.12, Pfizer Inc.  fell 2.32% to $27.79, and Eli Lilly & Co.  fell 2.21% to $1,123.91.Trading volume  eclipsed its 50-day average volume of 9.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHE","LU1934455194.USD","IYH","LU0265550946.USD","LU1116320901.HKD","LU2112291526.USD","IE0002141913.USD","SG9999015341.SGD","LU1917777945.USD","LU1162221912.USD","LU2125909593.SGD","LU1093756325.SGD","IE00BN8TJ469.HKD","LU0985320562.USD","LU1571399168.USD","LU2357627491.SGD","LU2125154778.USD","LU2125909247.SGD","LU1069347547.HKD","SGXZ57979304.SGD","BK4007","LU1061106388.HKD","LU0211331839.USD","TRUH","LU1585245621.USD","JDOC","GDOC","LU0942090050.USD","LU1057294990.SGD","PPH","LU1989772840.SGD","IE00BJT1NW94.SGD","LU0238689110.USD","IE00BLSP4452.SGD","LU1699723380.USD","LU1032466523.USD","LU0208291251.USD","LU1430594728.SGD","BK4550","LU2324357040.USD","IE00B4R5TH58.HKD","LU0234572021.USD","IE000M9KFDE8.USD","LU2461242641.AUD","IE00BSNM7G36.USD","LU1023059063.AUD","LU1934455863.HKD","LU2361045086.USD","FHLC","LU0432979614.USD","MRK","LU1983299246.USD","LU1066051811.HKD","LU0868494708.USD","SG9999013999.USD","LU1201861249.SGD","LU0265550359.USD","LU0965509283.SGD","LU0130517989.USD","LU0203345920.USD","LU0823416689.USD","SG9999014567.USD","PAWZ","LU0965509010.AUD","SG9999014542.SGD","IE00BLSP4239.USD","LU1934455277.USD","LU1116320737.USD","SG9999014575.USD","LU0098860793.USD","LU0965508806.USD","LU1037948541.HKD","LU1941712264.USD","LU1974910355.USD","IXJ","LU1923622614.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","LU0965509101.SGD","LU0861579265.USD","LU1941712348.USD","BK4588","LU2433249047.HKD","HRTS","SG9999014559.SGD","BK4533","BMED","LU0130102774.USD","LU0266013472.USD","LU0477156953.USD","LU0106261372.USD","LU0868494617.USD","LU2125154935.USD","LU1037948897.HKD","LU2491049909.HKD","VHT","SG9999001176.USD","LU0289739699.SGD","LU1929549753.HKD","IE00BBT3K403.USD","LU1291159041.SGD","XLV","LU0648001328.SGD","LU0859254822.USD","SG9999002232.USD","LU0980610538.SGD","IE0009355771.USD","LU0689626769.HKD","RXL","BK4534","BK4585","LU0124676726.USD","LU2361044865.SGD","SG9999015358.SGD","LU2023250504.SGD","IE00B1BXHZ80.USD","LU2361044949.HKD","IE00BJJMRZ35.SGD","FTXH","LU1066051225.USD","LU2468319806.SGD","LU1066053197.SGD","LU2023250843.SGD","BK4516","LU1066051498.USD","SG9999002224.SGD","LU2106854487.HKD","LU1093756168.USD","SG9999001176.SGD","LU0058720904.USD","LU2491050071.SGD","LU1989771016.USD","LU0203347892.USD","LU2360032135.SGD","LU2491050154.USD","IE00B2B36J28.USD","LU1989772923.USD","LU1035773651.USD","LU0320765489.SGD","LU0006306889.USD","LU0070302665.USD","BK4559","SG9999001440.SGD","LU2089984988.USD","LU0320765646.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666031372","title":"Protagonist Therapeutics Launches USD 300 Million Share Buyback Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666031372","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666031372?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897932,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics launches USD 300 million share buyback programProtagonist Therapeutics launched a share repurchase program for up to USD 300 million of outstanding common stock.Funding planne","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLc74SRP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","TRUH","LU1267930813.SGD","LU2430703095.HKD","IYH","LU1145028129.USD","SG9999001176.SGD","LU1718418525.SGD","FTXH","JNJ","LU0058720904.USD","PJP","IE00BFXG1179.USD","LU1032955483.USD","IHE","LU2487616109.SGD","BK4007","LU0820562030.AUD","XLV","SGXZ80539844.SGD","IE0009355771.USD","FHLC","GDOC","LU0683600562.USD","PTGX","RXL","IE00B42XCP33.USD","IXJ","SG9999001440.SGD","IE0002141913.USD","BMED","LU1551013342.USD","LU1066051225.USD","LU1778281490.HKD","JDOC","LU1057294990.SGD","LU2468319806.SGD","LU0689472784.USD","LU1506573853.SGD","LU2750360641.GBP","LU1244550221.USD","IE00BDGV0183.EUR","VHT","LU2602419157.SGD","IE00B4R5TH58.HKD","IE00B19Z3B42.SGD","IE00BGHQF631.EUR","MEDX","BK4504","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666914372","title":"Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.25% on Sep 8: Facts Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2666914372","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666914372?lang=en_us&edition=fundamental","pubTime":"2026-09-09 03:15","pubTimestamp":1788894935,"startTime":"0","endTime":"0","summary":"• Bristol-Myers Squibb faced profit-taking despite positive Phase 2 trial results for arlocabtagene autoleucel.\n• Investors reacted cautiously due to unspecified regulatory timelines and recent clinical trial enrollment pauses.\n• The company reports $48.19B in annual revenue and maintains solid financial operating metrics.","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262156735-market-movers-bmy-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","LU0061475181.USD","LU2596442595.SGD","IE00BFTCPJ56.SGD","LU0321505868.SGD","LU0096364046.USD","LU0456855351.SGD","LU1585245621.USD","LU1093756168.USD","LU0237698245.USD","LU2242646821.SGD","BK4585","LU0267386448.USD","LU1236620834.HKD","LU1989771016.USD","IE00BSNM7G36.USD","LU1032466523.USD","LU2360032135.SGD","LU1883839398.USD","LU2125154778.USD","LU2242652126.USD","BK4007","LU0432979614.USD","LU1323610961.USD","LU1430594728.SGD","IE00BFXG1179.USD","LU1868836591.USD","LU1093756325.SGD","LU1868836757.USD","BK4532","IE00BJJMRZ35.SGD","LU0882574055.USD","LU1261432733.SGD","LU0985481810.HKD","LU1074936037.SGD","IHE","LU0306806265.USD","LU0114720955.EUR","BK4588","BMY","BK4581","FTXH","LU0868494617.USD","LU1868837300.USD","LU1236620750.USD","LU1670710588.SGD","LU1983299246.USD","BK4534","IE0009355771.USD","IE00BJT1NW94.SGD","LU0306807586.USD","LU0321505439.SGD","LU1670711040.USD","LU1718418525.SGD","LU1291159041.SGD","LU1670710661.SGD","IE0002141913.USD","LU0225284248.USD","LU1868836914.USD","LU1670711123.USD","LU2125154935.USD","LU1868837136.USD","IE00B2B36J28.USD","LU2133065610.SGD","BK4559","LU0225771236.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374281","title":"Eli Lilly Stock (LLY) Falls on Competitor Novartis’ Cholesterol Drug Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374281","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374281?lang=en_us&edition=fundamental","pubTime":"2026-09-09 02:03","pubTimestamp":1788890602,"startTime":"0","endTime":"0","summary":"Cardiovascular disease treatments are potentially lucrative for the pharma industry.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/eli-lilly-stock-lly-falls-on-news-of-competitor-novartis-cholesterol-drug-setback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/eli-lilly-stock-lly-falls-on-news-of-competitor-novartis-cholesterol-drug-setback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","LU0689472784.USD","HRTS","LU0210536198.USD","LU0683600562.USD","OZEM","LU2462591350.SGD","LU0353189763.USD","LU1814569148.SGD","SG9999018857.SGD","LU0672654240.SGD","LU2750360641.GBP","LU0316494557.USD","LU1145028129.USD","LU2168563687.JPY","LU2471134879.HKD","LU2357305700.SGD","LU0708995401.HKD","LU0345770993.USD","LU1127390331.HKD","LU0320765059.SGD","LU0320765992.SGD","LU0203202063.USD","LU0882574139.USD","LU2168564222.USD","LU2089284900.SGD","LU0964807845.USD","LU0133085943.USD","LU2236285917.USD","IHE","MHIP","LU0106261372.USD","LU2552382132.HKD","GDOC","SGXZ81514606.USD","LU2756315664.SGD","LU2471134952.CNY","LU2264538146.SGD","IE0005OL40V9.USD","LU0820562030.AUD","LU1989771016.USD","LU0234572021.USD","LU2237443895.HKD","LU1720051108.HKD","LU1983299246.USD","LU0823416689.USD","LU0943347566.SGD","SG9999013999.USD","LU1804176565.USD","LU2265009873.SGD","SG9999015952.SGD","LU0289739699.SGD","IXJ","IYH","IE00B7KXQ091.USD","LU1974910355.USD","IE00B1BXHZ80.USD","LU2461242641.AUD","LU0353189680.USD","LU2023251221.USD","LU2237443382.USD","LU2168564495.EUR","BK4516","IE00BK4W5L77.USD","LU0006306889.USD","LU1868837300.USD","THNR","LU1868837136.USD","LU2168564149.EUR","LLII","IE00B1XK9C88.USD","IE00BJLML261.HKD","LU2456880835.USD","LU0225283273.USD","LU2112291526.USD","LU0432979614.USD","SG9999014898.SGD","BK4588","LU2361044865.SGD","LU0354030511.USD","LU2023250330.USD","LU0820561909.HKD","LU2023250504.SGD","LU0109391861.USD","LU1069344957.HKD","LU2237443978.SGD","IE00BJJMRZ35.SGD","WDNA","PPH","LU0094547139.USD","IE0004445015.USD","LU0238689110.USD","LU1548497426.USD","LU1988902786.USD","LU2324357040.USD","LU0079474960.USD","LU2552382058.USD","RXL","LU2237443465.HKD","LU2746668461.USD","SG9999015978.USD","CANC","XLV","LU0174119429.USD","LU0882574055.USD","LU0456855351.SGD","LU1291159041.SGD","LU1979441026.SGD","LU1366192091.USD","LU1629891620.HKD","LU0640476718.USD","LU0109394709.USD","LU0471298777.SGD","LU1280957306.USD","LU2602419157.SGD","LU2361044949.HKD","LU1551013342.USD","MEDI","LU0471298694.HKD","LU0823434740.USD","LU2087625088.SGD","AGNG","LU0820561818.USD","LU1868836914.USD","LU2417539215.USD","LU2468319806.SGD","SG9999014914.USD","BK4007","LU2271345857.HKD","LU0203201768.USD","LU2237438978.USD","IE00BFTCPJ56.SGD","LU0061475181.USD","LU0889565916.HKD","LU0787776722.HKD","LU2750360997.AUD","IE00BWXC8680.SGD","IE0002141913.USD","IE00B4JS1V06.HKD","LU2491050154.USD","LU1720051017.SGD","LU2361045086.USD","SG9999014906.USD","SGXZ99366536.SGD","LU0114720955.EUR","SGXZ31699556.SGD","SG9999001176.SGD","LU1551013425.SGD","LU0823434583.USD","LU2237443622.USD","IE0001KFT4U8.USD","LU1323610961.USD","CURE","MEDX","LU2111349929.HKD","IE00BJJMRY28.SGD","LU1917777945.USD","LU0466842654.USD","IE00B775H168.HKD","LU0058720904.USD","LU0096364046.USD","LU1035775433.USD","LU2491050071.SGD","SG9999001176.USD","IE00BFSS8Q28.SGD","LLYZ","LU1623119135.USD","LU0323591593.USD","LU1868836591.USD","IE00BJT1NW94.SGD","LU2106854487.HKD","LU2211815571.USD","ILDR","LU2552382215.SGD","IE00BN29S564.USD","BK4534","BK4599","GB00BDT5M118.USD","LU0256863811.USD","BK4533","LU2108987350.USD","SG9999015986.USD","IE0009355771.USD","LU1093756325.SGD","LU2746668974.SGD","LU2896262040.SGD","LU1267930730.SGD","LU0345770308.USD","ELIL","LLYX","LU2168564065.EUR","BK4581","IE00BKPKM429.USD","LU1868836757.USD","ELIS","LU1691799644.USD","VHT","IE00BFSS7M15.SGD","LU2237443549.SGD","LU2360106947.USD","LU2491049909.HKD","SGXZ57979304.SGD","IE00BKDWB100.SGD","LU0158827948.USD","IE00BK4W5M84.HKD","IE0004445239.USD","FTXH","LLY","LU1057294990.SGD","LU1232071149.USD","LU2089283258.USD","LU1093756168.USD","LU2089984988.USD","LU2213496289.HKD","SG9999015945.SGD","SG9999014880.SGD","IE00BJJMRX11.SGD","LU0266013472.USD","LU0256863902.USD","LU2063271972.USD","LU2462157665.USD","LU0354030438.USD","LU1061106388.HKD","LU0158827781.USD","JDOC","LU0786609619.USD","SGXZ51526630.SGD","LU2471134796.USD","LU1712237335.SGD","TRUH","LU1064131342.USD","LU2028103732.USD","FHLC","PJP","LU2756315318.SGD","SG9999018865.SGD","LU1023059063.AUD","LU0198837287.USD","SG9999017495.SGD","LU0122379950.USD","LU0417517546.SGD","LU0385154629.USD","LU2471134523.USD","TMED","BK4585","LU0097036916.USD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372374","title":"Royalty Pharma Down Nearly 6%, on Pace for Largest Percent Decrease Since March 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372374","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372374?lang=en_us&edition=fundamental","pubTime":"2026-09-09 01:26","pubTimestamp":1788888360,"startTime":"0","endTime":"0","summary":"Royalty Pharma Plc Class A  is currently at $60.20, down $3.76 or 5.88%--Would be lowest close since Aug. 18, 2026, when it closed at $59.69--On pace for largest percent decrease since March 26, 2025, when it fell 6.52%--Snaps a five-day winning streak--Down 1.97% month-to-date--Up 55.8% year-to-date--Down 5.88% from its all-time closing high of $63.96 on Sept. 4, 2026--Up 64.93% from 52 weeks ago , when it closed at $36.50--Down 5.88% from its 52-week closing high of $63.96 on Sept. 4, 2026--Up 72.49% from its 52-week closing low of $34.90 on Sept. 25, 2025--Traded as low as $58.63; lowest intraday level since Aug. 17, 2026, when it hit $58.18--Down 8.33% at today's intraday low; largest intraday percent decrease since June 19, 2020, when it fell as much as 8.53%All data as of 1:22:25 PM ETSource: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBE","IHE","BK4007","RPRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666737149","title":"Royalty Pharma Falls After Novartis' Cholesterol Drug Fails in Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2666737149","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666737149?lang=en_us&edition=fundamental","pubTime":"2026-09-09 00:40","pubTimestamp":1788885632,"startTime":"0","endTime":"0","summary":"BUZZ-Royalty Pharma falls after Novartis' cholesterol drug fails in study** Shares of Royalty PharmaRPRX.Ofall 6% to $60.14 in afternoon trade** RPRX buys royalties of future drugs from academic labs and biotechs** Swiss drugmaker Novartis'NOVN.Scholesterol drug pelacarsenfailsin a closely watched study** RPRX says its $500 million funding agreement with NOVN's partner IonisIONS.Owas structured to limit risk with stable and predictable royalties in another drug Spinraza and potential gains from pelacarsen** RPRX expects to recoup its total investment and earn a modest positive return despite pelacarsen's failure**  \"We had previously estimated combined 2032 end-market sales of $1.6B  and royalties of $80MM . A missed opportunity, but the growth outlook is little changed\" - Royalty Pharma** RPRX reiterates \"its 2030 Portfolio Receipts target of $4.7 billion or more\"** Including session's move, stock up 54.7% YTD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4501D1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","IE00BJJMRZ35.SGD","LU0320765992.SGD","BIB","LU0868494617.USD","LU1571399168.USD","BBH","BK4585","LU0109394709.USD","IE00B4R5TH58.HKD","LU0058720904.USD","IE0009355771.USD","BK4534","BK4533","LU2242652126.USD","PJP","BK4139","BK4581","LU1983299246.USD","BK4599","IE00BFTCPJ56.SGD","IHE","SG9999001440.SGD","LU2242646821.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","LU2112291526.USD","TBXU","AMGN","IE0002141913.USD","RPRX","LU1061106388.HKD","LU1023059063.AUD","PBE","IONS","IBB","LU0889565916.HKD","IBBQ","BK4566","BK4588","IE00B2B36J28.USD","LU0122379950.USD","BK4007","LU2468319806.SGD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665754593","title":"Dow Drops 438 Points on Losses for Amgen, Salesforce Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2665754593","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665754593?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:45","pubTimestamp":1788875100,"startTime":"0","endTime":"0","summary":"DJ Dow Drops 438 Points On Losses For Amgen, Salesforce SharesThis article was automatically generated by MarketWatch using technology from Automated Insights.The Dow Jones Industrial Average is declining Tuesday morning with shares of Amgen and Salesforce seeing the biggest declines for the blue-chip average.Shares of Amgen  and Salesforce  are contributing to the index's intraday decline, as the Dow  was most recently trading 438 points, or 0.8%, lower.Amgen's shares have declined $30.47, or 7.0%, while those of Salesforce have fallen $11.09, or 4.3%, combining for a roughly 247-point drag on the Dow.Also contributing significantly to the decline are Johnson & Johnson , IBM , and Microsoft .A $1 move in any of the Dow's 30 components equates to a 5.94-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2505996681.GBP","SDY","IE0004445239.USD","IE00B1XK9C88.USD","HK0000304805.HKD","SG9999014880.SGD","LU0345769631.USD","IE000M9KFDE8.USD","MYMmain","LU1778281490.HKD","SG9999014906.USD","IE00B2B36J28.USD","LU1201861165.SGD","SG9999015986.USD","BK4581","LU1935043023.USD","LU0143551892.USD","LU0096364046.USD","LU0345768153.USD","LU2244417387.USD","LU2023250843.SGD","LU1235294995.USD","IE0001KFT4U8.USD","LU2083900584.USD","LU1880398471.USD","LU2023250330.USD","LU0965509283.SGD","LU2750360997.AUD","SG9999014914.USD","LU0511384066.AUD","LU0882574055.USD","LU0432979614.USD","LU0980610538.SGD","FHLC","LU2265009873.SGD","LU0069063385.USD","IE00B775H168.HKD","LU0321505868.SGD","LU2360108059.USD","SG9999014559.SGD","LU2461242641.AUD","VUG","LU2089283258.USD","LU0871640123.AUD","LU1674673428.USD","CNEQ","LU0215105999.USD","LU2237443895.HKD","LU2168564149.EUR","MSFL","IE00B3SWFQ91.USD","LU1430594728.SGD","LU2237443465.HKD","LU1121112475.USD","IE0004445015.USD","LU0882574139.USD","LU1732800096.USD","LU0708994859.HKD","LU0314106906.USD","LU2242652126.USD","SG9999017495.SGD","LU0960925559.SGD","LU0056508442.USD","LU1506573853.SGD","GB00B4QBRK32.GBP","LU0198837287.USD","LU2552382058.USD","LU2361044865.SGD","PJP","LU0965509101.SGD","LU1074936037.SGD","LU0894486033.HKD","IHE","LU0889566641.SGD","IE00B7SZLL34.SGD","LU0061474960.USD","LU0251132253.USD","LU2125909593.SGD","LU0072461881.USD","LU2954938101.SGD","IE000F7OJYX1.SGD","SG9999014575.USD","LU2764263203.CNY","FTXH","GAMR","LU0320765489.SGD","IBX","LU1989773731.SGD","BK4007","BK4554","IE0003U64NQ7.SGD","LU1564329461.SGD","LU1923623000.USD","CRMG","LU0353189763.USD","BK4613","GRNY","IE0002141913.USD","LU0949170426.SGD","LU2433249047.HKD","BK4575","LU0316494557.USD","LU0124676726.USD","WQTM","LU1291159041.SGD","LU0128525929.USD","LU2242650005.HKD","LU2417539215.USD","LU0353189680.USD","LU0158827781.USD","BBH","SG9999018865.SGD","LU1181866309.USD","LU2491050154.USD","IE00BLSP4239.USD","LU0174119429.USD","LU2102340556.USD","LU0238689110.USD","LU0149725797.USD","LU0225283273.USD","LU0323239441.USD","SG9999015952.SGD","LU1894683348.USD","LU1791710582.SGD","LU2111349929.HKD","LU2357305700.SGD","MSFX","IE00BSNM7G36.USD","IE00BJJMRZ35.SGD","LU0823434583.USD","FDN","IE00BKPKM429.USD","LU0820561818.USD","LU1582987324.SGD","IE000KEQY171.SGD","LU0943347566.SGD","LU2999663052.SGD","LU2108987350.USD","EFIV","MSFC","SGXZ81514606.USD","LU0048584097.USD","LU2552382132.HKD","IE00BQXX3C00.GBP","LU0095938881.EUR","LU0138981039.USD","LU1633808545.USD","LU2746668974.SGD","SG9999014542.SGD","LU2403377893.USD","LU1670627923.USD","LU0187121727.USD","HK0000532082.HKD","LU2125154778.USD","LU1803068979.SGD","BK4534","IE000MB6IJN5.SGD","LU2764262908.HKD","IXJ","IE00BZ1G4Q59.USD","LU1564329115.USD","LU2087621335.USD","BK4550","LU2491050071.SGD","LU0052756011.USD","DIA","LU2092937221.SGD","LU1868836914.USD","LU1066051225.USD","LU0345770993.USD","LU2237443382.USD","LU2279689827.SGD","MGK","LU0098860793.USD","LU1061106388.HKD","LU1119994496.HKD","LU2362540622.SGD","LU1235295455.SGD","LU2191332357.HKD","BK4548","BK4559","LU0302445910.USD","LU2720916845.USD","LU1548497426.USD","LU0456855351.SGD","LU2430703095.HKD","SG9999001077.SGD","LU0949170772.SGD","LU1989764664.SGD","LU0256863902.USD","IE00B19Z9505.USD","LU2065170008.USD","LU2092627202.USD","LU1267930813.SGD","IE00B7KXQ091.USD","LU2458330243.SGD","LU3102509885.SGD","LU1188199696.SGD","LU1979441026.SGD","LU0320765059.SGD","DGRO","LU0965508806.USD","NULC","IE00BLSP4452.SGD","LU1935042991.SGD","LU2543165471.USD","LU0823421416.USD","VYMI","LU0203347892.USD","IE00BK4W5L77.USD","BK4585","SGXZ23171101.USD","LU2404859741.USD","LU0210528500.USD","LU1221951046.USD","LU0320765992.SGD","LU0683600562.USD","LU1244550577.SGD","IE0009356076.USD","IE00B3PB1722.GBP","IE000ITXATA3.USD","LU2168564495.EUR","LU1935043452.HKD","IE0002270589.USD","LU0787776722.HKD","LU2168564222.USD","LU2087625088.SGD","LU0757359368.USD","LU1145028129.USD","LU1989763005.USD","SG9999015978.USD","IE00B4YYXB79.USD","LU0082616367.USD","LU1202635105.USD","LU1301847155.USD","LU2361044949.HKD","IE00BFSS8Q28.SGD","LU2097829019.USD","LU2236285917.USD","TBXU","LU0208291251.USD","IE00B3S45H60.SGD","IE00BDRTCR15.USD","LU1316542783.SGD","LU0058720904.USD","LU2125154935.USD","LU2112291526.USD","LU1935042488.USD","LU0472753341.HKD","LU1974910355.USD","LU1066051811.HKD","04332","LU2275660780.HKD","LU2468319806.SGD","DOG","LU0308772762.SGD","LU2237957902.USD","IE00BN8TJ469.HKD","LU0859254822.USD",".DJI","LU2430703178.SGD","AMGN","IE00B4JS1V06.HKD","LU1323610961.USD","IE00B42XCP33.USD","UDOW","SG9999004303.SGD","LU1244550221.USD","VHT","LU2054465674.USD","LU2129689514.USD","LU0079474960.USD","LU1629891620.HKD","LU1823568750.SGD","LU0784385170.HKD","LU0256863811.USD","LU0203345920.USD","LU0690374961.EUR","LU0426412945.USD","BK4588","IE00BJTD4V19.USD","SG9999002224.SGD","LU2250418816.HKD","LU1670711123.USD","LU2125909247.SGD","LU1334329650.SGD","LU0545039389.USD","LU1582987597.SGD","LU2211815571.USD","DGRW","LU2106854487.HKD","LU2237957811.SGD","BK4567","HK0000914686.HKD","LU1228905037.USD","LU1236620750.USD","LU1691799644.USD","LU0784384876.USD","HK0000819398.USD","LU0053666078.USD","LU1582986359.USD","LU0444973449.USD","LU1059921491.USD","LU2458330169.SGD","LU0130517989.USD","LU0122379950.USD","XLI","IE00BYQQ9H92.USD","LU2041044095.USD","IE00BJJMRX11.SGD","LU2065171402.SGD","SG9999001176.USD","LU2746668461.USD","IXN","LU1366192091.USD","IE0034235295.USD","OGIG","LU0661504455.SGD","SG9999018857.SGD","LU2047632596.USD","IE00BFXG1179.USD","LU1923622614.USD","LU2097344431.USD","LU0070217475.USD","LU2271345857.HKD","LU0158827948.USD","LU0170899867.USD","LU1951198990.SGD","IE00B4R5TH58.HKD","LU2357627491.SGD","MEDX","LU0203202063.USD","IE00BFSS7M15.SGD","IE00BK4W5M84.HKD","IE000BZT7R73.USD","LU2506951958.HKD","LU1934455863.HKD","LU0276348264.USD","BK4503","LU2462591350.SGD","LU0965509010.AUD","SG9999015945.SGD","LU0912757837.SGD","LU1564329628.SGD","LU1839511570.USD","BK4568","LU2242649171.HKD","LU1582986433.USD","BK4533","LU0130102774.USD","IGV","IE0005OL40V9.USD","LU0553294199.USD","IE000WAW04H5.SGD","LU0354030511.USD","LU0708995401.HKD","IE00BKVL7J92.USD","LU1670710661.SGD","LU2298321311.HKD","LU0057025933.USD","LU0823417737.USD","LU0265550946.USD","LU0323240290.USD","LU1721428933.USD","IE00BJJMRY28.SGD","TYLG","LU1814569148.SGD","LU0289739699.SGD","LU1037948897.HKD","LU2129689431.USD","TDIV","LU0426417589.USD","LU1674673691.USD","BK4612","IE00BMPRXN33.USD","LU0545562505.USD","BK4505","LU0348723411.USD","TTXU","SG9999015341.SGD","LU1670710588.SGD","DJX","BK4139","BK4579","IE00BQXX3D17.EUR","LU1035775433.USD","LU2764263039.SGD","BK4607","LU0861579265.USD","LU1032955483.USD","LU2552382215.SGD","LU0061475181.USD","LU2023251221.USD","LU2213496289.HKD","LU1366333091.USD","LU2471134952.CNY","IBBQ","LU0395794307.EUR","LU1989772923.USD","SCHG","HK0000914660.USD","LU0130518102.USD","LU2100268510.USD","LU1496350171.SGD","TRUH","BK4532","LU1267930490.SGD","HK0000304797.USD","LU0466842654.USD","LU0784385840.USD","LU1914381329.SGD","LU0788109477.HKD","LU2756315664.SGD","LU1496350502.SGD","SGXZ31699556.SGD","SG9999014567.USD","BK4538","LU0690374615.EUR","LU0077335932.USD","LU2065169927.USD","LU2430703251.USD","LU0823434740.USD","LU0726765562.USD","LU1564329032.USD","IE00BGHQF631.EUR","SGXZ99366536.SGD","BK4516","LU1400636574.HKD","IE00B19Z8X17.USD","LU2023250504.SGD","LU1815336760.USD","LU2210149790.SGD","LU0823421333.USD","LU1988902786.USD","LU0792757196.USD","BK4543","IE00BVYPNW00.USD","LU1032466523.USD","LU1934455194.USD","SG9999001440.SGD","LU0289960550.SGD","LU0795875169.SGD","LU2487616109.SGD","LU0157215616.USD","LU1340139317.AUD","SKYY","SG9999001176.SGD","LU0080751232.USD","LU0894485498.HKD","LU0795875086.SGD","ROM","LU1791710400.SGD","LU0094547139.USD","FDVV","LU0203201768.USD","LU2237438978.USD","MSFT","LU2413666426.HKD","LU1064131342.USD","BK4527","LU2404859667.USD","LU0689626769.HKD","LU0345770308.USD","LU1852331112.SGD","LU2602419157.SGD","LU0310800379.SGD","SG9999000418.SGD","LU0320765646.SGD","LU2413666699.HKD","LU2028103732.USD","LU1935042215.USD","LU1720051108.HKD","LU0289941410.SGD","BK4525","LU0128525689.USD","LU1066051498.USD","LU2462591277.SGD","LU0784383803.USD","LU1880398554.USD","LU1400636491.USD","LU0640476718.USD","LU0109394709.USD","LU0211328371.USD","LU1732799900.SGD","LU2089984988.USD","LU1232071149.USD","LU0342679015.USD","LU2077746001.SGD","LU0312595415.SGD","LU2133065610.SGD","BK4592","LU2637965513.SGD","LU1221951129.SGD","SGXZ57979304.SGD","LU0323591593.USD","LU1228905540.USD","LU1868837300.USD","BK4602","LU1043141123.HKD","BK4561","LU0477156953.USD","IE0000B7K699.USD","LU1244550494.USD","LU2452424414.USD","LU0345774631.USD","LU1043141396.HKD","LU0321505439.SGD","LU2095319765.USD","LU2097344357.USD","BK4599","LU1267930730.SGD","BK4598","LU2750360641.GBP","IE000W1ABFV2.USD","LU1057294990.SGD","IE000SO60NU8.SGD","LU0048573561.USD","DVY","LU0061474705.USD","LU2360032135.SGD","LU1003077747.HKD","MSFD","LU0251142724.SGD","SG9999015358.SGD","LU1066053197.SGD","LU0072462426.USD","TOPT","LU1280957306.USD","LU2347655073.USD","SG9999002232.USD","XLK","IE0004091025.USD","LU0390134368.USD","IBM","BK4134","BIB","LU1989764748.USD","BK4576","SMSFTmain","LU0724617625.USD","LU0029864427.USD","JDOC","LU1815333072.USD","BK4577","LU0345769128.USD","LU1868836591.USD","LU1697837992.HKD","IE00BMPRXR70.SGD","LU1670711040.USD","FTEC","LU0106261372.USD","LU0289961442.SGD","IE0004086264.USD","IE00BWXC8680.SGD","LU2237443978.SGD","LU0823417653.USD","BK4566","LU0154236417.USD","LU1670628061.USD","LU2471134796.USD","SCHD","MSFO","MSFW","LU1069344957.HKD","BK4023","LU2506952170.USD","DDM","LU0957808578.USD","LU2505996509.AUD","LU1571399168.USD","LU2326559502.SGD","LU2168563687.JPY","CMAG","LU0171293334.USD","LU0689472784.USD","LU1201861249.SGD","LU1935043536.SGD","SG9999014898.SGD","LU0310799852.SGD","LU1153585028.USD","LU1670756490.USD","LU0738911758.USD","LU0266013472.USD","LU1162221912.USD","IE00BJTD4N35.SGD","LU0096362180.USD","LU0130103400.USD","LU0648001328.SGD","IYH","IE00BMPRXQ63.HKD","LU0133085943.USD","SGXZ51526630.SGD","LU0251131958.USD","IE00BFXG0V08.USD","LU0234572021.USD","LU0345768740.USD","IE00B5949003.HKD","IE00B3T34201.USD","LU0127658192.USD","LU2362541273.HKD","LU0289739343.SGD","LU1803068623.USD","LU2491049909.HKD","LU2456880835.USD","LU1934455277.USD","LU2089284900.SGD","LU0265550359.USD","GB00BDT5M118.USD","LU1267930227.SGD","SDOW","LU1712237335.SGD","LU2463028550.USD","SIBM0main","LU1645745479.HKD","LU1429558221.USD","LU2471134523.USD","LU1046421795.USD","LU2462157665.USD","LU2168564065.EUR","SG9999001424.SGD","LU2896262040.SGD","LU2237443622.USD","LU1718418525.SGD","LU1400636657.SGD","LU2264538146.SGD","LU1720051017.SGD","LU1196500208.SGD","SNPE","LU0950375773.USD","LU1983260115.SGD","LU2286300806.USD","LU1929549753.HKD","LU0267386448.USD","IE00B775SV38.USD","LU0985320562.USD","LU1868836757.USD","LU2237443549.SGD","DJIA","IE00BHPRN162.USD","LU2129689605.HKD","LU0081259029.USD","IE0034235303.USD","LU1236620834.HKD","LU0642271901.SGD","DXD","BMED","LU0354030438.USD","IE0009355771.USD","LU1983299246.USD","BK4608","LU0314104364.USD","IE00BFTCPJ56.SGD","LU1642822529.SGD","LU1868837136.USD","IE00B1BXHZ80.USD","LU0070302665.USD","LU0868494617.USD","LU0114720955.EUR","SG9999013999.USD","BK4535","BK4528","LU2347655156.SGD","LU2506951875.HKD","LU0310800965.SGD","LU1116320737.USD","LU1116320901.HKD","LU0557290698.USD","BK4097","LU0820562030.AUD","LU0889565916.HKD","LU0210533765.USD","LU1804176565.USD","BK4504","LU0889565833.HKD","LU2092937148.SGD","LU2063271972.USD","IE0034235188.USD","RXL","IE00BYXW3230.USD","LU0757359954.USD","LU0476273544.USD","LU1435385759.SGD","IE00B5TLWC47.USD","LU0494093205.USD","LU0347712357.USD","LU2361045086.USD","LU0175139822.USD","LU2420271590.USD","IE00BJLML261.HKD","YMAX","LU0648000940.SGD","LU1861127337.USD","IE00BDCRKT87.USD","LU2592432038.USD","LU0162691827.USD","LU0444971666.USD","LU1037948541.HKD","LU0011850046.USD","IE00B19Z3581.USD","LU0107464264.USD","LU0211327993.USD","LU0345774391.USD","LU1623119135.USD","LU0672654240.SGD","IE00B19Z8W00.USD","PBE","LU2247934214.USD","LU0477156797.USD","LU2242646821.SGD","LU2362541513.USD","LU2065171311.SGD","SPTE","CRM","LU0994945656.USD","LU2471134879.HKD","LU1989771016.USD","IE00BKDWB100.SGD","LU1023059063.AUD","LU1883839398.USD","MSFY","LU0234570918.USD","IE00BN29S564.USD","LU0528227936.USD","LU2860962120.EUR","IE0009G5SDU7.USD","LU0417517546.SGD","MSFU","LU1261432733.SGD","LU1551013342.USD","GDOC","LU0097036916.USD","LU2360106780.USD","LU1894683264.USD","LU1917777945.USD","LU2210150020.SGD","LU2756315318.SGD","VYM","SGXZ80539844.SGD","LU1069347547.HKD","LU0820561909.HKD","LU0879622024.SGD","LU0006306889.USD","LU0211331839.USD","LU1551013425.SGD","LU0109391861.USD","IE000YTNTUN2.SGD","GB00B4LPDJ14.GBP","LU1267930573.SGD","LU0957791311.USD","LU1127390331.HKD","IBB","LU1035773651.USD","IE00BDGV0183.EUR","LU0742534661.SGD","LU1084165304.USD","LU2381873111.SGD","LU1585245621.USD","LU2148611432.USD","IE00B19Z3B42.SGD","IE00BVYPNV92.GBP","VGT","LU2506952097.USD","IE00BJT1NW94.SGD","LU1951200564.SGD","IE00BQXX3F31.USD","LU1989772840.SGD","BK4587","JNJ","LU0964807845.USD","LU0109392836.USD","XLV","LU0210536198.USD","LU0719512351.SGD","IE00BBT3K403.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327289","title":"Johnson & Johnson Innovation Names Silvia Chen Head of JLABS Shanghai","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327289","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327289?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:43","pubTimestamp":1788867829,"startTime":"0","endTime":"0","summary":"Johnson & Johnson Innovation names Silvia Chen head of JLABS ShanghaiJohnson & Johnson Innovation-JJDC appointed Silvia Chen as site head of JLABS Shanghai.Chen brings more than two decades in healthc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL9xctQs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1718418525.SGD","LU0820561909.HKD","IE00BZ1G4Q59.USD","LU1066051498.USD","LU1496350502.SGD","XLV","LU1551013425.SGD","LU2089984988.USD","JDOC","LU0820562030.AUD","LU2456880835.USD","RXL","IXJ","VHT","BMED","LU0203345920.USD","FHLC","IE00B3T34201.USD","LU0426412945.USD","LU0640476718.USD","IHE","LU2471134523.USD","TRUH","LU0432979614.USD","LU1244550577.SGD","IE00B19Z3581.USD","FTXH","LU2505996509.AUD","IYH","LU0795875169.SGD","BK4504","LU0882574055.USD","IE000SO60NU8.SGD","LU1043141396.HKD","MEDX","LU2471134952.CNY","LU2750360641.GBP","LU0345770993.USD","LU2505996681.GBP","GDOC","LU1280957306.USD","LU0058720904.USD","LU1674673428.USD","LU0689626769.HKD","PJP","LU2129689605.HKD","LU0210528500.USD","JNJ","IE0009355771.USD","LU1066053197.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665473327","title":"Bristol Myers Squibb's Phase 2 Study of Arlocabtagene Autoleucel Meets Key Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2665473327","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665473327?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:41","pubTimestamp":1788867677,"startTime":"0","endTime":"0","summary":"Bristol Myers Squibb  said Tuesday that its CAR-T cell therapy arlocabtagene autoleucel met the primary and secondary endpoints of a phase 2 trial to treat adults with quadruple-class exposed relapsed and refractory multiple myeloma.The company said the study's results met its primary endpoint of demonstrating a statistically significant and clinically meaningful overall response rate in heavily pretreated adults with the blood cancer with at least four lines of therapy. It also said the study met key secondary endpoints, including a complete response rate in patients with at least three previous lines of therapy.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1236620834.HKD","BMY","LU1291159041.SGD","LU0868494617.USD","LU1430594728.SGD","LU1868836914.USD","LU0985481810.HKD","LU0096364046.USD","BK4588","FTXH","LU0267386448.USD","LU1883839398.USD","LU0237698245.USD","LU2125154935.USD","BK4559","LU1989771016.USD","IE00BJJMRZ35.SGD","LU1670711123.USD","IE00BSNM7G36.USD","IE00BJT1NW94.SGD","BK4581","LU1236620750.USD","BK4585","LU1323610961.USD","LU2242652126.USD","LU0321505439.SGD","IE00B2B36J28.USD","LU1868836757.USD","LU0432979614.USD","LU1032466523.USD","LU1093756325.SGD","LU1718418525.SGD","LU0306806265.USD","BK4007","LU1868837300.USD","LU0882574055.USD","LU1585245621.USD","LU1868836591.USD","LU1571399168.USD","LU1670711040.USD","LU1074936037.SGD","IHE","LU0306807586.USD","LU1261432733.SGD","IE0002141913.USD","LU0225284248.USD","LU1868837136.USD","LU0225771236.USD","LU1670710588.SGD","LU0061475181.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665327821","title":"Bristol Myers’ arlocabtagene autoleucel shows positive results in Phase 2 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665327821","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665327821?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:11","pubTimestamp":1788865885,"startTime":"0","endTime":"0","summary":"Bristol Myers (BMY) announced positive Phase 2 results from the registrational QUINTESSENTIAL trial of arlocabtagene autoleucel in adult patients w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bristol-myers-arlocabtagene-autoleucel-shows-positive-results-in-phase-2-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bristol-myers-arlocabtagene-autoleucel-shows-positive-results-in-phase-2-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1868837300.USD","LU2133065610.SGD","BK4534","LU0868494617.USD","LU1718418525.SGD","MYE","BK4585","BBC","LU1093756325.SGD","LU2125154935.USD","BMY","IE0002141913.USD","LU0114720955.EUR","LU1236620834.HKD","LU1093756168.USD","LU1868836914.USD","LU1670711123.USD","LU1670710588.SGD","LU0985481810.HKD","BK4588","LU0237698245.USD","BK4559","LU2360032135.SGD","LU1989771016.USD","IE00BFTCPJ56.SGD","LU1074936037.SGD","LU1430594728.SGD","LU0267386448.USD","LU1983299246.USD","LU1883839398.USD","IE00BJJMRZ35.SGD","LU2596442595.SGD","LU1670710661.SGD","LU1236620750.USD","LU0432979614.USD","BK4126","LU1261432733.SGD","LU0061475181.USD","LU1032466523.USD","LU0456855351.SGD","IE00BSNM7G36.USD","LU2242652126.USD","LU0225284248.USD","LU0321505868.SGD","LU1291159041.SGD","IHE","IE0009355771.USD","LU0882574055.USD","PSIL","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665832218","title":"Bristol Myers Squibb's Therapy Meets Mid-Stage Trial Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2665832218","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665832218?lang=en_us&edition=fundamental","pubTime":"2026-09-08 19:03","pubTimestamp":1788865386,"startTime":"0","endTime":"0","summary":"Bristol Myers Squibb's therapy meets mid-stage trial goalSept 8 (Reuters)-Bristol Myers SquibbBMY.Nsaid on Tuesday its experimental cell therapy met the main goal of a mid-stage trial.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4N4500S1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","IE00BJJMRZ35.SGD","LU0237698245.USD","LU1670711123.USD","LU1989771016.USD","LU0306806265.USD","LU1670710588.SGD","LU1983299246.USD","LU0061475181.USD","BK4588","LU0432979614.USD","LU1883839398.USD","LU1093756168.USD","BK4585","LU0225284248.USD","LU1868836591.USD","LU1261432733.SGD","LU0985481810.HKD","LU1868836914.USD","LU0882574055.USD","LU1718418525.SGD","IHE","IE0002141913.USD","LU2596442595.SGD","LU1670710661.SGD","LU0868494617.USD","LU1074936037.SGD","LU1236620750.USD","LU0096364046.USD","LU1430594728.SGD","LU2360032135.SGD","LU2125154935.USD","BMY","LU1868837300.USD","LU2242652126.USD","LU2133065610.SGD","IE00BFTCPJ56.SGD","LU0114720955.EUR","LU1093756325.SGD","BK4534","IE00BSNM7G36.USD","LU1032466523.USD","LU1291159041.SGD","LU0321505868.SGD","IE0009355771.USD","LU1236620834.HKD","LU0267386448.USD","LU0306807586.USD","LU0456855351.SGD","FTXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322873","title":"Bristol Myers Squibb Announces Positive Topline Results from Registrational Phase 2 Quintessential Trial of the Potential First-in-Class Gprc5d-Directed Car T Cell Therapy, Arlocabtagene Autoleucel ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322873","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322873?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:59","pubTimestamp":1788865140,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA7SSM6X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0002141913.USD","LU2125154778.USD","IE00BJT1NW94.SGD","LU1883839398.USD","LU1670711040.USD","IE0009355771.USD","LU0096364046.USD","LU1670710661.SGD","LU0267386448.USD","BMY","LU0321505868.SGD","LU1291159041.SGD","LU1236620834.HKD","LU1670711123.USD","LU1074936037.SGD","LU1430594728.SGD","LU1983299246.USD","LU0985481810.HKD","LU0456855351.SGD","IE00BFXG1179.USD","LU0868494617.USD","LU0432979614.USD","LU2596442595.SGD","LU0321505439.SGD","LU1261432733.SGD","LU1032466523.USD","LU0114720955.EUR","LU0306806265.USD","BK4588","IE00B2B36J28.USD","LU2242652126.USD","LU1236620750.USD","LU2125154935.USD","IHE","LU1868836591.USD","LU1989771016.USD","FTXH","IE00BSNM7G36.USD","LU1093756168.USD","LU1868837300.USD","IE00BJJMRZ35.SGD","LU0237698245.USD","BK4534","LU2242646821.SGD","BK4581","LU0225284248.USD","LU1093756325.SGD","LU2133065610.SGD","IE00BFTCPJ56.SGD","LU1323610961.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665322827","title":"Bristol-Myers Squibb Company - Phase 2 Trial Met Primary Endpoint of Overall Response Rate and Complete Response Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2665322827","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665322827?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:59","pubTimestamp":1788865140,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA7SSM6X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1983299246.USD","LU1868837300.USD","LU1868836914.USD","IHE","IE00BFXG1179.USD","LU0985481810.HKD","LU2242646821.SGD","LU1670710661.SGD","IE0002141913.USD","LU1585245621.USD","LU1989771016.USD","LU0321505439.SGD","LU0237698245.USD","LU0096364046.USD","LU1074936037.SGD","LU0306806265.USD","BK4585","LU1670711040.USD","LU0456855351.SGD","LU1670711123.USD","IE0009355771.USD","IE00BJT1NW94.SGD","LU1032466523.USD","LU0061475181.USD","IE00BSNM7G36.USD","LU1571399168.USD","LU1236620834.HKD","LU0267386448.USD","LU0306807586.USD","LU1323610961.USD","LU2125154778.USD","LU2360032135.SGD","FTXH","LU0225771236.USD","LU1093756168.USD","BMY","IE00BJJMRZ35.SGD","BK4581","LU0225284248.USD","BK4534","LU2133065610.SGD","BK4559","LU0432979614.USD","LU1868836591.USD","BK4532","LU0882574055.USD","LU1236620750.USD","LU2242652126.USD","LU1291159041.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}